Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use JESDUVROQ safely and effectively. See full prescribing information for JESDUVROQ. JESDUVROQ (daprodustat) tablets, for oral useInitial U.S. Approval: 2023
Medication labelWhy this: Advisory · dailymed-prescription
JESDUVROQ is indicated for the treatment of anemia due to chronic kidney disease (CKD) in adults who have been receiving dialysis for at least four months. Limitations of Use JESDUVROQ has not been shown to improve quality of life, fatigue, or patient well-being. JESDUVROQ is not indicated for use: •As a substitute for red blood cell transfusions in patients who require immediate correction of anemia. •For treatment of anemia of chronic kidney disease in patients who are not on dialysis.
- generic_name
- daprodustat
- product_names
- daprodustat
- ndc
- 0173-0897, 0173-0897-13, 0173-0897-56, 0173-0903, 0173-0903-13, 0173-0903-56, 0173-0906, 0173-0906-13, 0173-0906-56, 0173-0911, 0173-0911-13, 0173-0911-56, 0173-0914, 0173-0914-13, 0173-0914-56
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en